Lung Cancer - Genentech reports 48% spike in profit

Genentech reports 48% spike in profit
MarketWatch - 23 hours ago... Genentech also announced Tuesday that it had filed to have Avastin approved to treat lung cancer. The company requested that the ...
Source: www.marketwatch.com